Analystreport

SpringWorks Therapeutics (NASDAQ: SWTX) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating.

SpringWorks Therapeutics, Inc. - common stock  (SWTX) 
Last springworks therapeutics, inc. - common stock earnings: 3/12 04:30 pm Check Earnings Report